June 5, 2003
Dr. Krick new Chairman of the Supervisory Board of Fresenius AG
Annual General Meeting approves 10 % dividend increase
At its constituent meeting today, the Supervisory Board of Fresenius AG chose Dr. Gerd Krick to be its new Chairman. Dr. Krick had handed over the chairmanship of the Managing Board, as already announced, to Dr. Ulf M. Schneider at the close of the Annual General Meeting and was voted onto the Supervisory Board. Dr. Karl Schneider, the former speaker of the Managing Board of Südzucker AG, and Chairman of the Supervisory Board of Fresenius AG since 1998, continues to be on the Supervisory Board as an ordinary member. Gerd Holtgrefe from the trade union IGBCE was re-elected Deputy Chairman.
The following members of the Supervisory Board were re-elected by the Annual General Meeting:
- Dr. Gabriele Kröner, Munich
Doctor - Gerhard Roggemann, Hanover
Member of the Managing Board of WestLB AG, Düsseldorf/Münster - Dr. Dieter Schenk, Munich
Lawyer and tax consultant
Law office Nörr, Stiefenhofer & Lutz - Dr. Bernhard Wunderlin, Bad Homburg v.d.H.
Former Managing Director Harald Quandt Holding GmbH
Dr. Manfred Schaudwet did not stand for re-election to the Supervisory Board.
The employees of Fresenius AG had already elected the following as their representatives:
- Arnold Danneck, St. Wendel
Chairman of the General Works Council - Christel Neumann, Schweinfurt
Chairman of the Works Council Schweinfurt plant - Ilona Oesterle, Bad Homburg v.d.H.
Deputy Chairlady of the General Works Council
The executive staff elected:
- Dr. Bernd Mathieu, St. Wendel
Business unit Patents
as their representative.
The following representatives of the trade unions were elected:
- Gerhard Herres, DHV
- Gerd Holtgrefe, IGBCE
At today's (28.5.2003) Annual General Meeting the shareholders of the health care company Fresenius approved by a large majority the proposal of the Managing Board and Supervisory Board to increase the dividend by around 10%. Thus, the owners of an ordinary share will receive 1.14 euros (2002: 1.03 euros), the owners of a preference share 1.17 euros (2002: 1.06 euros) per share.
In addition, the Annual General Meeting approved changes to the Articles of Association in accordance with the recommendation of the Corporate Governance Code and agreed to a conditional increase of the subscribed capital in order to issue convertible bonds to employees due to the 2003 stock option plan.
91.89% of the ordinary share capital was represented at the Annual General Meeting of Fresenius AG, and 28.66% of the preference share capital, making 60.29% of total capital.
Fresenius is a health care company operating all over the world with products and services for dialysis, the hospital and the medical care of patients at home. Sales amounted to 7.5 billion euros in 2002, and net income 134 million euros. On December 31, 2002 the Fresenius Group employed 63,638 employees all over the world.